Abstract
Human papillomavirus (HPV) causes cervical cancer among women and is associated with other anogenital cancers in men and women. Prophylactic particulate vaccines that are affordable, self-administered and efficacious could improve uptake of HPV vaccines world-wide. The goal of this research is to develop a microparticulate HPV16 vaccine for transdermal administration using AdminPatch® and assess its immunogenicity in a pre-clinical mouse model. HPV16 microparticles were prepared using a biocompatible polymer and characterized in terms of size, zeta potential, encapsulation efficiency and microparticle yield. Scanning and transmission electron microscopy were conducted to confirm particle image and to visualize the conformation of HPV16 vaccine particles released from microparticle formulation. In vivo studies performed to evaluate the potential of the microparticulate vaccine initiated a robust and sustained immune response. HPV16 IgG antibodies were significantly elevated in the microparticle group compared to antigen solutions administered by the transdermal route. Results show significant expansion of CD4+, CD45R, CD27 and CD62L cell populations in the vaccinated mice group, indicating the high efficacy of the microparticulate vaccine when administered via transdermal route. The findings of this study call attention to the use of minimally invasive, pain-free routes to deliver vaccine.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference31 articles.
1. Classification of papillomaviruses
2. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
3. Sexually Transmitted Infections (STIs)
https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)
4. A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
5. Human Papillomavirus (HPV)
http://www.who.int/immunization/diseases/hpv/en/#
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献